ArticlePediatric research2026
Age-specific ETCOc measured by non-dispersive infrared spectroscopy predicts neonatal phototherapy.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnd-tidal carbon monoxide corrected for ambient carbon monoxide (ETCOc), a noninvasive marker of bilirubin production, may help identify neonates at risk for significant hyperbilirubinemia. We aimed to construct an age-specific ETCOc percentile distribution and evaluate its value in predicting phototherapy.
methodsIn this prospective observational study, neonates underwent serial ETCOc measurements at predefined postnatal time points. Age-specific percentile curves were constructed to describe serial postnatal changes in ETCOc. Receiver operating characteristic analysis was used to assess the predictive performance of ETCOc for phototherapy, and logistic regression was performed to evaluate its independent association with phototherapy risk.
resultsETCOc showed clear age-specific serial changes during the early neonatal days. The highest AUC values were observed at 24 and 72 h. Although 72-h ETCOc yielded a slightly higher AUC, the difference was not significant by DeLong test. The AUC of 24-h ETCOc for predicting phototherapy was 0.87 (95% CI: 0.79-0.96). A 24-h ETCOc value above the 75th percentile was associated with increased phototherapy risk, and logistic regression further supported its predictive value.
conclusionsETCOc may be a useful early noninvasive marker for predicting phototherapy in neonates. Age-specific, percentile-based interpretation, particularly at 24 h above the 75th percentile, may improve early risk stratification. IMPACT: ETCOc demonstrated dynamic age-specific changes during the early neonatal period, supporting age-related interpretation rather than a single fixed cutoff. Unlike conventional electrochemical CO sensing approaches, this study applied infrared spectroscopy-based ETCOc measurement throughout the analytical process for neonatal monitoring. A 24-h ETCOc value above the 75th percentile identified neonates at increased risk for subsequent phototherapy. ETCOc may provide a simple, noninvasive tool for early risk stratification and monitoring of neonatal hyperbilirubinemia.
Identifiers
42469415What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.